Trial intelligence / Profile preview

Dasatinib plus standard chemotherapy in newly diagnosed pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia

2011-001123-20Phase 2Completed

Sponsor

Bristol Myers Squibb

Start

Dec 2011

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1